CFHI(SH:601106)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was CNY 4,496,792,675, representing a year-on-year increase of 6.52%[4] - The net profit attributable to shareholders was CNY 37,283,622.49, showing a decrease of 3.62% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 11,783,954.76, down 62.75% year-on-year[4] - Total operating revenue for Q1 2023 was ¥4,496,792,675, an increase of 6.5% compared to ¥4,221,704,188 in Q1 2022[18] - Net profit for Q1 2023 was ¥39,952,313.25, slightly higher than ¥39,060,899.35 in Q1 2022, representing a growth of 2.3%[19] - The total comprehensive income for Q1 2023 was ¥39,952,313.25, compared to ¥39,060,899.35 in Q1 2022, indicating a slight increase of 2.3%[20] Cash Flow - The net cash flow from operating activities was negative CNY 456,043,738.62, an increase of 4.15% compared to the previous year[5] - Cash inflow from operating activities in Q1 2023 was ¥3,615,761,389.58, an increase from ¥3,195,740,017.80 in Q1 2022, showing a growth of 13.1%[21] - The net cash flow from operating activities was -456,043,738.62, an improvement from -475,798,437.58 in the previous year[22] - The net increase in cash from operating activities of ¥3,615,761,389.58, compared to ¥3,195,740,017.80 in the previous year, reflecting a positive cash flow trend[21] - The total cash outflow from operating activities amounted to 4,071,805,128.20, an increase from 3,671,538,455.38 year-over-year[22] - The net cash flow from financing activities increased to 1,253,730,660.04, up from 1,080,854,828.56 year-over-year[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 44,317,623,708.37, an increase of 7.41% from the end of the previous year[5] - Total liabilities increased to ¥32,413,512,155.75 from ¥29,394,975,048.38, reflecting a rise of approximately 6.9%[16] - The total owner's equity reached ¥11,904,111,552.62, compared to ¥11,865,844,329.45, reflecting a growth of approximately 0.3%[16] - The total liabilities to total assets ratio is approximately 73.1%, indicating a high leverage position[16] Research and Development - The company's R&D expenses increased by 87.94%, reflecting a commitment to enhance technological innovation[10] - Research and development expenses for Q1 2023 were ¥137,893,440.06, significantly higher than ¥73,372,101.05 in Q1 2022, marking an increase of 88.2%[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 258,685, with the largest shareholder holding 63.88% of the shares[11] Government Subsidies - The company received government subsidies amounting to CNY 6,242,751.27, which are closely related to its normal business operations[6] Investment Income - The company reported a significant decrease of 61.84% in investment income, primarily due to lower equity method investment returns[10] - Investment income for Q1 2023 was ¥47,099,326.39, down from ¥123,421,402.78 in Q1 2022, a decline of 61.9%[19]